Skip to content

Prediction of Clinical Efficacy of Systemic Therapy in Sarcoma Patients: A Retrospective Study

Prediction of Clinical Efficacy of Systemic Therapy in Sarcoma Patients: A Retrospective Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091252
Enrollment
Unknown
Registered
2024-10-23
Start date
2024-11-01
Completion date
Unknown
Last updated
2024-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone sarcoma

Interventions

Case series:NA

Sponsors

The Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Received MDT diagnosis and treatment services at the Comprehensive Diagnosis and Treatment Center for Bone and Soft Tissue Tumors of the Shanghai Sixth People's Hospital of the National Orthopedic Center or various cooperative medical institutions; 2. Age = 10 years old, gender not limited; 3. Imaging examination suggests sarcoma, confirmed by surgery or biopsy pathology, and received neoadjuvant therapy, postoperative adjuvant therapy, or palliative treatment at Shanghai Sixth People's Hospital or various cooperative medical institutions; 4. Provided informed consent form.

Exclusion criteria

Exclusion criteria: 1. Simultaneously suffering from other types of malignant tumors; 2. Vasodilatory osteosarcoma;

Design outcomes

Primary

MeasureTime frame
Drug efficacy;

Secondary

MeasureTime frame
Measurable lesion diameter;Number of non-measurable lesions;

Countries

China

Contacts

Public ContactAina He

The Sixth People's Hospital

anna_1188@126.com+86 189 3017 2898

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026